1. Home
  2. NUVB vs JBSS Comparison

NUVB vs JBSS Comparison

Compare NUVB & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • JBSS
  • Stock Information
  • Founded
  • NUVB 2018
  • JBSS 1959
  • Country
  • NUVB United States
  • JBSS United States
  • Employees
  • NUVB N/A
  • JBSS N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • NUVB Health Care
  • JBSS Consumer Staples
  • Exchange
  • NUVB Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • NUVB 679.9M
  • JBSS 794.3M
  • IPO Year
  • NUVB N/A
  • JBSS 1991
  • Fundamental
  • Price
  • NUVB $2.12
  • JBSS $62.14
  • Analyst Decision
  • NUVB Strong Buy
  • JBSS
  • Analyst Count
  • NUVB 5
  • JBSS 0
  • Target Price
  • NUVB $8.20
  • JBSS N/A
  • AVG Volume (30 Days)
  • NUVB 4.2M
  • JBSS 82.4K
  • Earning Date
  • NUVB 05-07-2025
  • JBSS 04-30-2025
  • Dividend Yield
  • NUVB N/A
  • JBSS 3.37%
  • EPS Growth
  • NUVB N/A
  • JBSS N/A
  • EPS
  • NUVB N/A
  • JBSS 4.72
  • Revenue
  • NUVB $10,957,000.00
  • JBSS $1,107,742,000.00
  • Revenue This Year
  • NUVB $95.27
  • JBSS N/A
  • Revenue Next Year
  • NUVB $345.44
  • JBSS N/A
  • P/E Ratio
  • NUVB N/A
  • JBSS $13.16
  • Revenue Growth
  • NUVB N/A
  • JBSS 7.40
  • 52 Week Low
  • NUVB $1.54
  • JBSS $58.47
  • 52 Week High
  • NUVB $3.97
  • JBSS $105.63
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 47.71
  • JBSS 45.47
  • Support Level
  • NUVB $2.14
  • JBSS $61.17
  • Resistance Level
  • NUVB $2.42
  • JBSS $62.65
  • Average True Range (ATR)
  • NUVB 0.16
  • JBSS 1.60
  • MACD
  • NUVB -0.01
  • JBSS 0.29
  • Stochastic Oscillator
  • NUVB 27.71
  • JBSS 59.91

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: